Quality of life of HIV patients in a rural area of Western Uganda: Impact of a community-based antiretroviral treatment program

Current HIV Research

Volumn 8, Issue 5, 2010, Pages 370-378

  Alibhai, Arif ^a   Martin, Leah J ^a   Kipp, Walter ^a   Konde Lule, Joseph ^b   Saunders, L Duncan ^a   Rubaale, Tom ^c   Houston, Stan ^a   Okech Ojony, Joa ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MAKERERE UNIVERSITY   (Uganda)

^c Kabarole Health Department   (Uganda)

Author keywords

Antiretroviral therapy; Community based treatment; HIV AIDS; Quality of life; Rural health services; Uganda

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL STUDY; COGNITION; FAMILY; FEMALE; FRIEND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PUBLIC HEALTH; QUALITY OF LIFE; RURAL AREA; SCORING SYSTEM; SOCIAL STATUS; TREATMENT OUTCOME; UGANDA; WELLBEING; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RURAL POPULATION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UGANDA;

EID: 77954695993     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210791330400     Document Type: Article

References (45)

1. UNAIDS. Towards universal access: scaling up priority HIV/AIDSinterventions in the health sector: Progress report, April 2007. Geneva:World Health Organization 2007.
2. Stock R. Distance and the utilization of health facilities in rural Nigeria.Soc Sci Med 1983; 17(9): 563-70.
3. Buor D. Analysing the primacy of distance in the utilization of healthservices in the Ahafo-Ano South district, Ghana. Int J Health PlannManage 2003; 18(4): 293-311.
4. Duff KP. Barriers to accessing and accepting highly active antiretroviraltherapy in Western Uganda [Masters of Science Thesis]. Edmonton,Canada: University of Alberta Fall 2007.
5. Johns B, Torres TT. Costs of scaling up health interventions: asystematic review. Health Policy Plan 2005; 20(1): 1-13.
6. Binswanger HP. Scaling up HIV/AIDS programs to national coverage.Science 2000; 288(5474): 2173-6.
7. UNAIDS. Towards universal access. Scaling up priority HIV/AIDSinterventions in the health sector. Progress report 2008. Geneva: WorldHealth Organization 2008.
8. Whyte SR, Whyte MA, Meinert L, Kyaddondo B. Treating AIDS:Dilemmas of unequal access in Uganda. SAHARA J 2004; 1(1): 14-26.
9. Farmer P, Leandre F, Mukherjee JS, et al. Community-basedapproaches to HIV treatment in resource-poor settings. Lancet 2001;358(9279): 404-9.
10. Kabarole District. District Information Portal. 2008 [August 12, 2008];Available from: http://www.kabarole.go.ug
11. Uganda Ministry of Health. Uganda HIV/AIDS sero-behavioral survey2004-2005. Kampala, Uganda July 2006.
12. Uganda Ministry of Health. National antiretroviral treatment and careguidelines for adults and for children. 1st Edition. Kampala, Uganda 2003.
13. Mugyenyi P, Walker AS, Hakim J, et al. Routine versus clinicallydriven laboratory monitoring of HIV antiretroviral therapy in Africa(DART): a randomised non-inferiority trial. Lancet 2010; 375(9709):123-31.
14. Kipp W, Konde-Lule J, Saunders LD, et al. Results of a Community-Based Antiretroviral Treatment Program for HIV-1 Infection inWestern Uganda. Curr HIV Res 2010; 8(2): 179-93.
15. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines forusing antiretroviral agents among HIV-infected adults and adolescents -The panel on clinical practices for treatment of HIV. Ann Intern Med 2002; 137(5): 381-433.
16. Walker SR, Rosser RM, Eds. Quality of Life: Assessment andApplication. Lancaster, England: MTP Press Limited 1988.
17. Murri R, Fantoni M, Del Borgo C, et al. Determinants of health-relatedquality of life in HIV-infected patients. AIDS Care 2003; 15(4): 581-90.
18. Delate T, Coons SJ. The use of 2 health-related quality-of-life measuresin a sample of persons infected with human immunodeficiency virus.Clin Infect Dis 2001; 32(3): E47-E52.
19. Wu AW. Quality of life assessment comes of age in the era of highlyactive antiretroviral therapy. AIDS 2000; 14(10): 1449-51.
20. Eriksson LE, Nordstrom G, Berglund T, Sandstrom E. The health-related quality of life in a Swedish sample of HIV-infected persons. JAdv Nurs 2000; 32(5): 1213-23.
21. Carrieri P, Spire B, Duran S, et al. Health-related quality of life after 1year of highly active antiretroviral therapy. J AIDS 2003; 32(1): 38-47.
22. Burgoyne R, Renwick R. Social support and quality of life over timeamong adults living with HIV in the HAART era. Soc Sci Med 2004;58(7): 1353-66.
23. Hughes J, Jelsma J, Maclean E, Darder M, Tinise X. The health-relatedquality of life of people living with HIV/AIDS. Disabil Rehabil 2004;26(6): 371-6.
24. Tramarin A, Campostrini S, Postma MJ, et al. A multicentre study ofpatient survival, disability, quality of life and cost of care: Amongpatients with AIDS in northern Italy. Pharmacoeconomics 2004; 22(1):43-53.
25. Booysen FLR, Van Rensburg HCJ, Bachmann M, Louwagie G, FairallL. The heart in HAART: Quality of life of patients enrolled in thepublic sector antiretroviral treatment programme in the Free Stateprovince of South Africa. Soc Indic Res 2007; 81(2): 283-329.
26. Poundstone KE, Strathdee SA, Celentano DD. The social epidemiologyof human immunodeficiency virus/acquired immunodeficiencysyndrome. Epidemiol Rev 2004; 26: 22-35.
27. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of themedical outcomes study health-related quality of life measures inHIV/AIDS. Qual Life Res 1997; 6(6): 531-54.
28. Revicki DA, Sorensen S, Wu AW. Reliability and validity of physicaland mental health summary scores from the medical outcomes studyHIV Health Survey. Med Care 1998; 36(2): 126-37.
29. Clayson DJ, Wild DJ, Quarterman P, Duprat-Lomon I, Kubin M,Coons SJ. A comparative review of health-related quality-of-lifemeasures for use in HIV/AIDS clinical trials. Pharmacoeconomics 2006; 24(8): 751-65.
30. Berzon R, Hays RD, Shumaker SA. International use, application andperformance of health-related quality-of-life instruments. Qual Life Res 1993; 2(6): 367-8.
31. Mast TC, Kigozi G, Wabwire-Mangen F, et al. Measuring quality oflife among HIV-infected women using a culturally adaptedquestionnaire in Rakai district, Uganda. AIDS Care 2004; 16(1): 81-94.
32. Lara MA, Wakholi NB, Munderi P, Watera C, Gilks CF, Grosskurth H.Performance Assessment of the MOS-HIV Health Survey in HIV-Infected Individuals in Entebbe, Uganda: Aug 2006; XVI InternationalAIDS Conference: \International AIDS Society, Toronto: Canada.
33. Stangl AL, Wamai N, Mermin J, Awor AC, Bunnell RE. Trends andpredictors of quality of life among HIV-infected adults taking highlyactive antiretroviral therapy in rural Uganda. AIDS Care 2007; 19(5):626-36.
34. Cohen C, Revicki DA, Nabulsi A, Sarocco PW, Jiang P. A randomizedtrial of the effect of ritonavir in maintaining quality of life in advancedHIV disease. AIDS 1998; 12(12): 1495-502.
35. van Leth F, Conway B, Laplume H, et al. Quality of life in patientstreated with first-line antiretroviral therapy containing nevirapine and/orefavirenz. Antivir Ther 2004; 9(5): 721-8.
36. Bajunirwe F, Tisch DJ, King CH, Arts EJ, Debanne SM, Sethi AK. Quality of life and social support among patients receiving antiretroviraltherapy in Western Uganda. AIDS Care 2009; 21(3): 271-9.
37. Weinfurt KP, Willke RJ, Glick HA, Freimuth WW, Schulman KA. Relationship between CD4 count, viral burden, and quality of life overtime in HIV-1-infected patients. Med Care 2000; 38(4): 404-10.
38. Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL. Construct validities of the quality of well-being scale andthe MOS-HIV-34 health survey for HIV-infected patients. Med DecisMaking 1997; 17(4): 439-46.
39. Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B. The use ofhighly active antiretroviral therapy (HAART) in patients with advancedHIV infection: Impact on medical, palliative care, and quality of lifeoutcomes. J Pain Symptom Manage 2001; 21(1): 41-51.
40. Bedingfield N. The psychosocial impact of highly active antiretroviraltherapy on patients and caregivers in Western Uganda: A qualitativestudy [Masters of Science Thesis]. Edmonton, Canada: University ofAlberta; Fall 2008.
41. Nyanzi WB, Medina LA, Munderi P, Gilks CF, Grosskurth H, Eds. Perceived changes and challenges in the quality of life of HIV infectedindividuals on ART: A qualitative study in Uganda: Aug 2006; XVI International AIDS Conference: International AIDS Society, Toronto:Canada.
42. Nyanzi WB, Medina LA, Munderi P, Gilks CF, Grosskurth H, Eds. HRQoL dimensions affected by antiretroviral therapy: a qualitativestudy in HIV-infected Ugandans: Oct 2006; 13th Annual Conference ofthe International Society for Quality of Life Research: InternationalSociety of Quality of Life, Lisbon: Portugal
43. Park-Wyllie LY, Strike CS, Antoniou T, Bayoumi AM. Adversequality of life consequences of antiretroviral medications. AIDS Care 2007; 19(2): 252-7.
44. Mutimura E, Stewart A, Crowther N. Assessment of quality of life inHAART-treated HIV-positive subjects with body fat redistribution inRwanda. AIDS Res Ther 2007; 4(1): 19.
45. Kipp W, Karamagi EBE, Tindyebwa D. AIDS-Related Stigma:Perceptions of Family Caregivers and Health Volunteers in WesternUganda. World Health Popul 2007; 9(2): 5-13.